- HK$11.10bn
- HK$15.54bn
- CNY6.14bn
- 56
- 62
- 78
- 78
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,358 | 5,540 | 5,200 | 5,982 | 6,143 |
Cost of Revenue | |||||
Gross Profit | 4,879 | 3,991 | 3,397 | 4,141 | 4,204 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4,430 | 4,175 | 4,876 | 4,841 | 4,768 |
Operating Profit | 1,928 | 1,364 | 324 | 1,141 | 1,375 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,634 | 942 | -74.6 | 670 | 700 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,354 | 703 | -145 | 583 | 539 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1,396 | 707 | -134 | 605 | 533 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,396 | 707 | -134 | 605 | 533 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.431 | 0.221 | 0.01 | 0.191 | 0.144 |
Dividends per Share |